3.53 USD
-0.01 (-0.28%)
Taking everything into account, ARQ scores 3 out of 10 in our fundamental rating. ARQ was compared to 83 industry peers in the Chemicals industry. ARQ has a bad profitability rating. Also its financial health evaluation is rather negative. ARQ is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ARQ has reported negative net income.
ARQ had a positive operating cash flow in the past year.
ARQ had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARQ reported negative operating cash flow in multiple years.
1.2 Ratios
ARQ's Return On Assets of -1.41% is in line compared to the rest of the industry. ARQ outperforms 42.17% of its industry peers.
ARQ has a Return On Equity (-1.81%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.41% | ||
| ROE | -1.81% | ||
| ROIC | N/A |
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 33.36%, ARQ is doing good in the industry, outperforming 66.27% of the companies in the same industry.
In the last couple of years the Gross Margin of ARQ has grown nicely.
The Profit Margin and Operating Margin are not available for ARQ so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
2. Health
2.1 Basic Checks
ARQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARQ has more shares outstanding
ARQ has more shares outstanding than it did 5 years ago.
ARQ has a better debt/assets ratio than last year.
2.2 Solvency
ARQ has an Altman-Z score of 2.24. This is not the best score and indicates that ARQ is in the grey zone with still only limited risk for bankruptcy at the moment.
ARQ's Altman-Z score of 2.24 is fine compared to the rest of the industry. ARQ outperforms 62.65% of its industry peers.
ARQ has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.11, ARQ belongs to the top of the industry, outperforming 90.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.24 |
ROIC/WACCN/A
WACC14.61%
2.3 Liquidity
ARQ has a Current Ratio of 1.10. This is a normal value and indicates that ARQ is financially healthy and should not expect problems in meeting its short term obligations.
ARQ has a worse Current ratio (1.10) than 87.95% of its industry peers.
ARQ has a Quick Ratio of 1.10. This is a bad value and indicates that ARQ is not financially healthy enough and could expect problems in meeting its short term obligations.
ARQ has a Quick ratio of 0.71. This is amonst the worse of the industry: ARQ underperforms 85.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
The earnings per share for ARQ have decreased strongly by -700.00% in the last year.
Looking at the last year, ARQ shows a small growth in Revenue. The Revenue has grown by 7.20% in the last year.
Measured over the past years, ARQ shows a quite strong growth in Revenue. The Revenue has been growing by 9.22% on average per year.
EPS 1Y (TTM)-700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%0.86%
3.2 Future
ARQ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.41% yearly.
The Revenue is expected to grow by 17.85% on average over the next years. This is quite good.
EPS Next Y1.3%
EPS Next 2Y5.11%
EPS Next 3Y41%
EPS Next 5Y42.41%
Revenue Next Year9.44%
Revenue Next 2Y14.19%
Revenue Next 3Y15.89%
Revenue Next 5Y17.85%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ARQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ARQ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
ARQ's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ARQ is more expensive than 65.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.49 |
4.3 Compensation for Growth
A more expensive valuation may be justified as ARQ's earnings are expected to grow with 41.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.11%
EPS Next 3Y41%
5. Dividend
5.1 Amount
No dividends for ARQ!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:ARQ (1/7/2026, 11:02:33 AM)
3.53
-0.01 (-0.28%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners39.02%
Inst Owner ChangeN/A
Ins Owners18.63%
Ins Owner Change-0.73%
Market Cap150.70M
Revenue(TTM)117.94M
Net Income(TTM)-3.92M
Analysts82.22
Price Target8.77 (148.44%)
Short Float %4.16%
Short Ratio3.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-184.29%
Min EPS beat(2)-278.18%
Max EPS beat(2)-90.4%
EPS beat(4)2
Avg EPS beat(4)-42.15%
Min EPS beat(4)-278.18%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)2.78%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.23%
Min Revenue beat(2)0.63%
Max Revenue beat(2)9.82%
Revenue beat(4)3
Avg Revenue beat(4)1.51%
Min Revenue beat(4)-7.12%
Max Revenue beat(4)9.82%
Revenue beat(8)6
Avg Revenue beat(8)4.7%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.53%
PT rev (3m)-19.63%
EPS NQ rev (1m)-71.43%
EPS NQ rev (3m)-400%
EPS NY rev (1m)-43.33%
EPS NY rev (3m)-2050%
Revenue NQ rev (1m)-1.83%
Revenue NQ rev (3m)-6.49%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-1.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.28 | ||
| P/FCF | N/A | ||
| P/OCF | 28.78 | ||
| P/B | 0.69 | ||
| P/tB | 0.72 | ||
| EV/EBITDA | 15.49 |
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)0.12
OCFY3.48%
SpS2.76
BVpS5.09
TBVpS4.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.41% | ||
| ROE | -1.81% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.36% | ||
| FCFM | N/A |
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
F-Score5
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.49 | ||
| Cap/Depr | 467.23% | ||
| Cap/Sales | 43.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 52.66% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 2.24 |
F-Score5
WACC14.61%
ROIC/WACCN/A
Cap/Depr(3y)475.88%
Cap/Depr(5y)322.19%
Cap/Sales(3y)39.34%
Cap/Sales(5y)27.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175%
EPS Next Y1.3%
EPS Next 2Y5.11%
EPS Next 3Y41%
EPS Next 5Y42.41%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%0.86%
Revenue Next Year9.44%
Revenue Next 2Y14.19%
Revenue Next 3Y15.89%
Revenue Next 5Y17.85%
EBIT growth 1Y-270.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year692.32%
EBIT Next 3Y155.12%
EBIT Next 5Y106.6%
FCF growth 1Y7.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119%
OCF growth 3Y-26.14%
OCF growth 5Y-29.98%
ARQ INC / ARQ FAQ
Can you provide the ChartMill fundamental rating for ARQ INC?
ChartMill assigns a fundamental rating of 3 / 10 to ARQ.
Can you provide the valuation status for ARQ INC?
ChartMill assigns a valuation rating of 1 / 10 to ARQ INC (ARQ). This can be considered as Overvalued.
How profitable is ARQ INC (ARQ) stock?
ARQ INC (ARQ) has a profitability rating of 2 / 10.
What is the financial health of ARQ INC (ARQ) stock?
The financial health rating of ARQ INC (ARQ) is 3 / 10.